Industry News
Strong demand in the pharmaceutical industry, expanding market size for vancomycin
Current Status of Vancomycin Market
The analysis of vancomycin market size data shows that in 2021, the total global vancomycin market size reached 3.727 billion yuan (RMB), while the Chinese vancomycin market size reached 955 million yuan (RMB), accounting for 25.62% of the total global vancomycin market share. The global and Chinese markets for vancomycin reached 4.111 billion yuan and 1.053 billion yuan respectively in 2022. During the 2021-2027 forecast period, it is expected that the vancomycin market will steadily grow at a compound annual growth rate of 10.65%, and the total global vancomycin market size is expected to reach 6.817 billion yuan by 2027.
Currently, vancomycin is widely used in clinical practice and remains an important choice for treating infections caused by drug-resistant Gram positive bacteria such as methicillin-resistant Staphylococcus aureus. However, with the excessive use of antibiotics and the increasing number of antibiotic resistant bacteria, the resistance to vancomycin has also become an increasingly problematic issue. In clinical practice, caution should be exercised in the use of vancomycin to avoid further development of antibiotic resistant bacteria.
Market demand for vancomycin
Gram positive bacterial infection treatment: Vancomycin is mainly used to treat infections caused by Gram positive bacteria such as methicillin-resistant Staphylococcus aureus (MRSA). These bacteria often cause serious diseases such as skin and soft tissue infections, respiratory infections, and sepsis. Due to the emergence of drug-resistant bacteria, traditional antibiotics have limited efficacy in treating these infections, while vancomycin is widely used in the treatment of these infections due to its high efficiency and low resistance.
Deep tissue and organ infections: Analysis of the market size of vancomycin mentioned that there is also a certain demand for vancomycin in the treatment of deep tissue and organ infections. It can be used to treat serious infections such as endocarditis, bone and joint infections, peritonitis, especially those caused by drug-resistant bacteria.
Drug resistant bacterial infection treatment: Analysis of the market size of vancomycin indicates that with the continuous increase of drug-resistant bacteria, finding effective treatment plans has become an urgent task. Vancomycin plays an important role in combating drug-resistant bacterial infections. Despite the development of resistance to vancomycin by drug-resistant bacteria, it remains one of the limited available antibiotics.
Hospital infection management: Hospital infection is a major global issue that has serious impacts on the healthcare system and patients. Vancomycin plays an important role in hospital infection management, especially in controlling and treating drug-resistant bacterial infections. The increasing demand for hospital infection management may drive the market demand for vancomycin.
Development background of vancomycin market
Discovery and preliminary application: Vancomycin was first isolated from Streptomyces orientalis by researchers from Eli Lilly in 1953. Initially, vancomycin was mainly used to treat Gram positive bacterial infections, especially for bacteria that develop resistance to other antibiotics.
Drug resistant bacteria and emerging demand: With the overuse of antibiotics, some bacteria are beginning to develop resistance to vancomycin. However, in the challenge of combating drug-resistant bacterial infections, the demand for vancomycin is gradually increasing, especially in the treatment of MRSA and other drug-resistant bacterial infections.
Research and Development: In order to overcome the challenge of antibiotic resistant bacteria, scientists have been working hard to develop new vancomycin derivatives and structural analogues to improve efficacy, reduce toxicity, and reduce bacterial resistance to them. The continuous research and innovation in this field have injected new vitality into the development of the vancomycin industry.
Global market expansion: With the improvement of medical standards on a global scale, the increase of hospital infection problems, and the threat of drug-resistant bacteria, the demand for vancomycin in in the market continues to expand. In addition, vancomycin is also widely used in the veterinary field to treat infectious diseases in animals, further expanding its market.
Future trends and challenges: With the strengthening of global antibiotic usage policies, the development of new antibiotics, and continuous improvement in the management of drug-resistant bacterial infections, the vancomycin industry will face new trends and challenges. For example, as the understanding of drug-resistant bacteria deepens, it may affect the use and scope of vancomycin.
Overall, the vancomycin industry has gone through a development process from initial discovery to application expansion, resistance challenges, and emerging demands. Its future development will continue to be influenced by various factors such as scientific research, medical demand, and market competition.
JIN DUN CHEMICAL has built a special (meth) acrylic monomer manufacturing base in ZHEJIANG province. This makes sure the stable supply of HEMA, HPMA, HEA, HPA, GMA with high level quality. Our special acrylate monomers are widely used for thermosetting acrylic resins, crosslinkable emulsion polymers, acrylate anaerobic adhesive, two-component acrylate adhesive, solvent acrylate adhesive, emulsion acrylate adhesive, paper finishing agent and painting acrylic resins in adhesive.We have also developed the new and special (meth) acrylic monomers and derivatives. Such as the fluorinated acrylate monomers, It can be widely used in coating leveling agent, paints, inks, photosensitive resins, optical materials, fiber treatment, modifier for plastic or rubber field. We are aiming to be the top supplier in the field of special acrylate monomers, to share our rich experience with better quality products and professional service.
